Brief: Cogent Biosciences Q1 EPS USD -0.62
07/05/2024 13:00
May 07 (Reuters) - Cogent Biosciences Q1 operating expenses USD 62.404 million. * Q1 net income USD -58.348 million * Q1 income from operations USD -62.404 million
Recent news on Cogent Biosciences
See all newsBrief: Cogent Biosciences - Enters Commercial Supply Agreement With Hovione On Sept 1, 2026 - SEC Filing
Brief: Cogent Biosciences - May Offer Up To $400 Million In Common Stock Through Guggenheim Securities
Cogent Biosciences Q2 net loss widens on higher expenses
Brief: Cogent Biosciences Q2 Net Income USD -96.405 Million
U.S. STOCKS ON THE MOVE-Snowflake, Best Buy, Kohl's